| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2036638
Max Phase: Preclinical
Molecular Formula: C15H13ClN2O2S
Molecular Weight: 320.80
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCOC(=O)c1cnc2ccc(Cl)cc2c1SCCC#N
Standard InChI: InChI=1S/C15H13ClN2O2S/c1-2-20-15(19)12-9-18-13-5-4-10(16)8-11(13)14(12)21-7-3-6-17/h4-5,8-9H,2-3,7H2,1H3
Standard InChI Key: OFIYQMZOBQYYFZ-UHFFFAOYSA-N
Associated Targets(Human)
Peptide N-myristoyltransferase 1 643 Activities
Peptide N-myristoyltransferase 2 44 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 320.80 | Molecular Weight (Monoisotopic): 320.0386 | AlogP: 4.07 | #Rotatable Bonds: 5 |
| Polar Surface Area: 62.98 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 2.18 | CX LogP: 3.39 | CX LogD: 3.39 |
| Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.47 | Np Likeness Score: -1.55 |
References
| 1. Goncalves V, Brannigan JA, Whalley D, Ansell KH, Saxty B, Holder AA, Wilkinson AJ, Tate EW, Leatherbarrow RJ.. (2012) Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode., 55 (7): [PMID:22439843] [10.1021/jm300040p] |
Source
Source(1):